Future studies conducted in disease cohorts of large sample size will be required to definitively assess the effect of LXRα haploinsufficiency on alcohol-related liver disease and determine whether LXRα modulates risk of liver cirrhosis in response to other hepatotoxic agents. The gene discussed is NR1H3; the disease is cirrhosis of liver.